SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001651308-18-000014
Filing Date
2018-12-12
Accepted
2018-12-11 17:36:56
Documents
4
Period of Report
2018-12-11
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K bgne-xform8xkreegmxxfinal1.htm 8-K 91659
2 EXHIBIT 3.1 fiftharmafinal.htm EX-3.1 310778
3 EXHIBIT 10.1 appendixb-2ndar2016planfin.htm EX-10.1 90804
4 EXHIBIT 10.2 appendixc-2nda_r2018esppfi.htm EX-10.2 47637
  Complete submission text file 0001651308-18-000014.txt   542376
Mailing Address C/O MOURANT OZANNES CORPORATE SERVICES 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT OZANNES CORPORATE SERVICES 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37686 | Film No.: 181229597
SIC: 2834 Pharmaceutical Preparations